Amarin Corp PLC (AMRN) stock
AMRNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 10/3061% above fair value
$11.26−0.01 (-0.09%)
Close on Nov 18, 2026Market cap $248.90MP/E –Yield –
Amarin net income
Net income is the profit left for shareholders after every expense, interest and tax.
Amarin's net income for the twelve months ending Sep 30, 2026 was -$19.14M. For fiscal 2025 it was -$38.80M. The highest annual figure on record is $7.73M in fiscal 2021.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$38.80M | – |
| FY2024 | Dec 31, 2024 | -$82.18M | – |
| FY2023 | Dec 31, 2023 | -$59.11M | – |
| FY2022 | Dec 31, 2022 | -$105.80M | -1468.9% |
| FY2021 | Dec 31, 2021 | $7.73M | – |
| FY2020 | Dec 31, 2020 | -$18.00M | – |
| FY2019 | Dec 31, 2019 | -$22.65M | – |
| FY2018 | Dec 31, 2018 | -$116.45M | – |
| FY2017 | Dec 31, 2017 | -$67.87M | – |
| FY2016 | Dec 31, 2016 | -$86.35M | – |
| FY2015 | Dec 31, 2015 | -$115.20M | – |
| FY2014 | Dec 31, 2014 | -$56.36M | – |
| FY2013 | Dec 31, 2013 | -$166.23M | – |
| FY2012 | Dec 31, 2012 | -$179.18M | – |
| FY2011 | Dec 31, 2011 | -$69.13M | – |
| FY2010 | Dec 31, 2010 | -$249.59M | – |
| FY2009 | Dec 31, 2009 | -$30.61M | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $245.00K | – |
| Q2 FY2026 | Jun 30, 2026 | -$7.65M | – |
| Q1 FY2026 | Mar 31, 2026 | -$10.51M | – |
| Q4 FY2025 | Dec 31, 2025 | -$1.22M | – |
| Q3 FY2025 | Sep 30, 2025 | -$7.74M | – |
| Q2 FY2025 | Jun 30, 2025 | -$14.14M | -1029.0% |
| Q1 FY2025 | Mar 31, 2025 | -$15.70M | – |
| Q4 FY2024 | Dec 31, 2024 | -$48.62M | – |
| Q3 FY2024 | Sep 30, 2024 | -$25.13M | – |
| Q2 FY2024 | Jun 30, 2024 | $1.52M | – |
| Q1 FY2024 | Mar 31, 2024 | -$9.95M | – |
| Q4 FY2023 | Dec 31, 2023 | -$5.78M | -775.4% |
| Q3 FY2023 | Sep 30, 2023 | -$19.31M | – |
| Q2 FY2023 | Jun 30, 2023 | -$17.56M | – |
| Q1 FY2023 | Mar 31, 2023 | -$16.46M | – |
| Q4 FY2022 | Dec 31, 2022 | $856.00K | -94.2% |
| Q3 FY2022 | Sep 30, 2022 | -$5.14M | – |
| Q2 FY2022 | Jun 30, 2022 | -$69.96M | -996.0% |
| Q1 FY2022 | Mar 31, 2022 | -$31.56M | – |
| Q4 FY2021 | Dec 31, 2021 | $14.70M | +198.4% |
| Q3 FY2021 | Sep 30, 2021 | -$13.15M | – |
| Q2 FY2021 | Jun 30, 2021 | $7.81M | +76.9% |
| Q1 FY2021 | Mar 31, 2021 | -$1.63M | – |
| Q4 FY2020 | Dec 31, 2020 | $4.93M | -30.3% |
| Q3 FY2020 | Sep 30, 2020 | -$6.79M | – |
| Q2 FY2020 | Jun 30, 2020 | $4.42M | – |
| Q1 FY2020 | Mar 31, 2020 | -$20.55M | – |
| Q4 FY2019 | Dec 31, 2019 | $7.07M | – |
| Q3 FY2019 | Sep 30, 2019 | -$3.46M | – |
| Q2 FY2019 | Jun 30, 2019 | -$1.82M | – |
| Q1 FY2019 | Mar 31, 2019 | -$24.43M | – |
| Q4 FY2018 | Dec 31, 2018 | -$33.67M | – |
| Q3 FY2018 | Sep 30, 2018 | -$24.47M | – |
| Q2 FY2018 | Jun 30, 2018 | -$34.21M | – |
| Q1 FY2018 | Mar 31, 2018 | -$24.10M | – |
| Q4 FY2017 | Dec 31, 2017 | -$22.47M | – |
| Q3 FY2017 | Sep 30, 2017 | -$10.83M | – |
| Q2 FY2017 | Jun 30, 2017 | -$13.63M | – |
| Q1 FY2017 | Mar 31, 2017 | -$20.94M | – |
| Q4 FY2016 | Dec 31, 2016 | -$27.45M | – |
See a number that looks wrong?